bm 13505 has been researched along with alprostadil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, KE; Hedlund, H; Holmquist, F | 1 |
| Arner, M; Högestätt, ED; Uski, TK | 1 |
| Kimblad, PO; Steen, S | 1 |
3 other study(ies) available for bm 13505 and alprostadil
| Article | Year |
|---|---|
Pre- and postjunctional effects of some prostanoids in human isolated vas deferens.
Topics: Adult; Alprostadil; Dinoprostone; Electric Stimulation; Humans; Iloprost; Isometric Contraction; Male; Middle Aged; Norepinephrine; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Vas Deferens | 1991 |
Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Alprostadil; Biphenyl Compounds; Dinoprost; Dinoprostone; Female; Hand; Humans; Male; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Sulfonamides; Thromboxanes; Veins | 1991 |
Eliminating the strong pulmonary vasoconstriction caused by Euro-Collins solution.
Topics: Alprostadil; Animals; Constriction, Pathologic; Drug Combinations; Drug Interactions; Endothelium, Vascular; Epoprostenol; Hypertonic Solutions; Models, Biological; Nifedipine; Papaverine; Phenylacetates; Pulmonary Artery; Severity of Illness Index; Sulfonamides; Swine; Thromboxane A2; Thromboxanes; Vasoconstriction; Vasodilator Agents | 1994 |